Health authorities are closely monitoring the spread of three new COVID-19 variants in the United States: EG.5, FL.1.5.1, and BA.2.86. EG.5 is currently the dominant strain, followed by FL.1.5.1. The highly mutated BA.2.86 variant is still relatively rare but has raised concerns due to its numerous mutations. Symptoms for these variants appear to be largely the same as previous strains, and COVID-19 tests are expected to work effectively against them. Vaccine makers anticipate that the upcoming COVID-19 booster shots will be effective against EG.5 and FL.1.5.1, but it remains uncertain if BA.2.86 could impact the effectiveness of the vaccines.
Health authorities are monitoring the spread of three new COVID-19 variants in the US: EG.5, FL.1.5.1, and BA.2.86. EG.5 is currently the dominant strain, followed by FL.1.5.1. These variants share a mutation known as F456L, which may contribute to their increased spread. Symptoms for these variants appear to be largely the same as previous strains, and COVID-19 tests are expected to work for them. Vaccine makers anticipate that the upcoming COVID-19 vaccine boosters will be effective against EG.5 and FL.1.5.1. However, it is uncertain whether BA.2.86 could impact the effectiveness of the vaccines.
As the EG.5 and FL.1.5.1 variants of COVID-19 continue to spread, a Staten Island infectious disease specialist advises vulnerable individuals, such as those over 65 or immunocompromised, to wear masks and be cautious. Both variants are descendants of the omicron variant and share similar symptoms. While hospitalizations have increased, respiratory failure is not commonly observed. The upcoming bivalent booster is expected to provide protection against these variants. People are advised to stay indoors if they test positive and to wear masks when going outside. The at-home COVID tests can detect the new variants, and individuals testing positive should avoid public spaces.
